Canopy Growth (CGC) EPS (Weighted Average and Diluted) Growth (3y) (2022 - 2025)
Canopy Growth (CGC) EPS (Weighted Average and Diluted) Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 52.55% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.07% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.19% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -46.43% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 64.08% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -19.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -16.96% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 260.88% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -100.00% |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 75.18% |
| Jun 30, 2025 | 66.19% |
| Mar 31, 2025 | 46.24% |
| Dec 31, 2024 | -52.94% |
| Sep 30, 2024 | -260.25% |
| Jun 30, 2024 | -54.83% |
| Mar 31, 2024 | 22.83% |
| Dec 31, 2023 | -3.09% |
| Sep 30, 2023 | -183.82% |
| Jun 30, 2023 | 13.21% |
| Sep 30, 2022 | -65.22% |